News

Three decades after Rae Lewis-Thornton became the face of HIV, the virus is still a major threat to Black women. She and experts explore why.
Learn about Zero HIV Stigma Day and its impact on reducing stigma and promoting awareness and testing in communities affected by HIV.
When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been ...
It is age-old information that mothers look out for their children, especially girls, when still in school and beyond. And ...
The Alabama Department of Public Health observes Zero HIV Stigma Day, urging public support to end stigma and foster inclusivity as part of a national HIV initiative.
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...
A Gilead Sciences drug that protects against HIV infection has won a highly anticipated FDA approval, becoming the first medication for HIV prevention available as a twice-yearly injection.
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
Prevention of HIV has become even easier with the FDA approval of lenacapavir (Yeztugo; Gilead Sciences), a twice-yearly long-acting injectable treatment that can prevent HIV in those who receive ...